| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 3 | -1,036,546 | 100% | $170.63 | -$176,864,258 |
| Net | -3 | -1,036,546 | -100% | -$176,864,258 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sylebra Capital Ltd | 10%+ Owner | $342,252,082 | 20 Nov 2023 | ||
| Daniel Patrick Gibson | Director | $261,951,169 | 05 Jun 2025 | ||
| SYLEBRA CAPITAL LLC | Other* | $170,230,374 | -$169,461,072 | -50% | 11 Dec 2025 |
| Chris Ph.d. Diorio | CHIEF EXECUTIVE OFFICER, Director | $81,699,253 | -$7,348,830 | -8.3% | 20 Feb 2026 |
| Cary Baker | Chief Financial Officer | $11,241,225 | 20 Feb 2026 | ||
| Jeffrey Dossett | Chief Revenue Officer | $7,345,346 | 20 Feb 2025 | ||
| Steve Sanghi | Director | $6,427,641 | 05 Jun 2025 | ||
| Hussein Mecklai | Chief Operating Officer | $5,066,641 | 12 Apr 2025 | ||
| Gregory Sessler | Director | $2,304,076 | 08 Jun 2023 | ||
| Peter H. van Oppen | Director | $1,978,650 | 09 Jun 2022 | ||
| Cathal G. Phelan | CHIEF INNOVATION OFFICER, Director | $1,859,543 | 20 May 2025 | ||
| Meera Rao | Director | $1,300,524 | 05 Jun 2025 | ||
| Theresa Wise | Director | $1,210,869 | 09 Jun 2022 | ||
| Umesh Padval | Director | $731,868 | 05 Jun 2025 | ||
| Miron Washington | Director | $624,858 | -$54,357 | -8% | 07 Nov 2025 |
| Arthur L. Valdez Jr. | Director | 20 Oct 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Cary Baker | PI | Common Stock | Tax liability | -2.48% | -2,234 | 87,877 | 20 Feb 2026 | Direct | ||
| Cary Baker | PI | Common Stock | Award | 10.4% | 8,508 | 90,111 | 20 Feb 2026 | Direct | ||
| Chris Ph.d. Diorio | PI | Common Stock | Tax liability | -1.89% | -7,435 | 386,885 | 20 Feb 2026 | Direct | ||
| Chris Ph.d. Diorio | PI | Common Stock | Award | 5.83% | 21,734 | 394,320 | 20 Feb 2026 | Direct | ||
| Chris Ph.d. Diorio | PI | Common Stock | Gift | -0.49% | -1,836 | 372,586 | 17 Feb 2026 | Direct | ||
| Chris Ph.d. Diorio | PI | Common Stock | Tax liability | -0.59% | -2,218 | 374,422 | 23 Dec 2025 | Direct | ||
| Chris Ph.d. Diorio | PI | Common Stock | Options Exercise | 1.52% | 5,635 | 376,640 | 23 Dec 2025 | Direct | ||
| Chris Ph.d. Diorio | PI | Restricted Stock Units | Options Exercise | -68.5% | -5,635 | 2,594 | 23 Dec 2025 | Direct | ||
| Cary Baker | PI | Common Stock | Tax liability | -0.89% | -732 | 81,603 | 23 Dec 2025 | Direct | ||
| Cary Baker | PI | Common Stock | Options Exercise | 2.31% | 1,856 | 82,335 | 23 Dec 2025 | Direct | ||
| Cary Baker | PI | Restricted Stock Units | Options Exercise | -70.4% | -1,856 | 782 | 23 Dec 2025 | Direct | ||
| Sylebra Capital Llc | PI | Common Stock | Sale | -10.6% | $20,242,816 | $150.36 | -134,629 | 1,132,152 | 15 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -3.84% | $7,415,013 | $146.62 | -50,573 | 1,266,781 | 12 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -6.75% | $14,575,390 | $152.87 | -95,345 | 1,317,354 | 11 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -5.65% | $13,155,321 | $155.49 | -84,604 | 1,412,699 | 10 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | $6,400 | $160.01 | -40 | 1,497,303 | 09 Dec 2025 | See Footnote | |
| Sylebra Capital Llc | PI | Common Stock | Sale | -0.17% | $400,835 | $160.72 | -2,494 | 1,497,343 | 08 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -0.09% | $221,108 | $161.04 | -1,373 | 1,499,837 | 05 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -0.21% | $508,589 | $160.59 | -3,167 | 1,501,210 | 04 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -2.67% | $6,923,891 | $167.97 | -41,221 | 1,504,377 | 03 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -2.64% | $7,044,463 | $168.23 | -41,874 | 1,545,598 | 02 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -1.92% | $5,187,307 | $167.02 | -31,058 | 1,587,472 | 01 Dec 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -1.36% | $3,848,908 | $172.62 | -22,297 | 1,618,530 | 28 Nov 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -2.06% | $5,936,721 | $171.80 | -34,556 | 1,640,827 | 26 Nov 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -2.68% | $7,734,030 | $167.73 | -46,110 | 1,675,383 | 25 Nov 2025 | See Footnote |
| Cary Baker | PI | Common Stock | Gift | -1.23% | -1,000 | 80,479 | 25 Nov 2025 | Direct | ||
| Sylebra Capital Llc | PI | Common Stock | Sale | -1.82% | $5,093,788 | $159.42 | -31,952 | 1,721,493 | 24 Nov 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -0.17% | $472,426 | $155.10 | -3,046 | 1,753,445 | 21 Nov 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -0.46% | $1,263,262 | $156.32 | -8,081 | 1,756,491 | 20 Nov 2025 | See Footnote |
| Chris Ph.d. Diorio | PI | Common Stock | Gift | -1.85% | -7,000 | 371,005 | 19 Nov 2025 | Direct | ||
| Sylebra Capital Llc | PI | Common Stock | Sale | -0.21% | $589,564 | $156.30 | -3,772 | 1,764,572 | 12 Nov 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -1.67% | $4,668,900 | $155.63 | -30,000 | 1,768,344 | 11 Nov 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -0.35% | $1,012,851 | $162.16 | -6,246 | 1,798,344 | 07 Nov 2025 | See Footnote |
| Miron Washington | PI | Common Stock | Sale | -14.4% | $54,357 | $158.94 | -342 | 2,040 | 07 Nov 2025 | Direct |
| Sylebra Capital Llc | PI | Common Stock | Sale | -1.27% | $3,981,846 | $171.95 | -23,157 | 1,804,590 | 06 Nov 2025 | See Footnote |
| Sylebra Capital Llc | PI | Common Stock | Sale | -0.08% | $305,641 | $202.01 | -1,513 | 1,827,747 | 03 Nov 2025 | See Footnote |
| Chris Ph.d. Diorio | PI | Common Stock | Options Exercise | 6.63% | 23,500 | 378,005 | 30 Oct 2025 | Direct | ||
| Chris Ph.d. Diorio | PI | Stock Option (right to buy) | Options Exercise | -100% | -23,500 | 0 | 30 Oct 2025 | Direct | ||
| Arthur L. Valdez Jr. | PI | Restricted Stock Units | Award | 1,220 | 1,220 | 20 Oct 2025 | Direct | |||
| Chris Ph.d. Diorio | PI | Common Stock | Tax liability | -0.62% | -2,219 | 354,505 | 23 Sep 2025 | Direct | ||
| Chris Ph.d. Diorio | PI | Common Stock | Options Exercise | 1.61% | 5,636 | 356,724 | 23 Sep 2025 | Direct | ||
| Chris Ph.d. Diorio | PI | Restricted Stock Units | Options Exercise | -52.1% | -5,636 | 5,188 | 23 Sep 2025 | Direct | ||
| Cary Baker | PI | Common Stock | Tax liability | -0.89% | -732 | 81,479 | 23 Sep 2025 | Direct | ||
| Cary Baker | PI | Common Stock | Options Exercise | 2.31% | 1,857 | 82,211 | 23 Sep 2025 | Direct | ||
| Cary Baker | PI | Restricted Stock Units | Options Exercise | -54.3% | -1,857 | 1,563 | 23 Sep 2025 | Direct | ||
| Chris Ph.d. Diorio | PI | Common Stock | Options Exercise | 18.2% | 54,075 | 351,088 | 18 Sep 2025 | Direct | ||
| Chris Ph.d. Diorio | PI | Stock Option (right to buy) | Options Exercise | -100% | -54,075 | 0 | 18 Sep 2025 | Direct | ||
| Chris Ph.d. Diorio | PI | Common Stock | Sale | -1.36% | $768,515 | $187.63 | -4,096 | 297,013 | 16 Sep 2025 | Direct |
| Chris Ph.d. Diorio | PI | Common Stock | Sale | -1.63% | $909,647 | $181.93 | -5,000 | 301,109 | 15 Sep 2025 | Direct |
| Chris Ph.d. Diorio | PI | Common Stock | Gift | -8.93% | -30,000 | 306,109 | 12 Sep 2025 | Direct |